Quest Diagnostics and ServiceNow raised their full-year forecasts following strong second-quarter results. Quest's profit growth was driven by robust demand for routine diagnostic testing, while ServiceNow increased its subscription revenue outlook due to rapid AI product adoption. After ServiceNow beat earnings estimates, Wall Street analysts updated their price targets for the company's stock.
